Skip to main content
. Author manuscript; available in PMC: 2017 Jun 2.
Published in final edited form as: Stat Biopharm Res. 2016 Jun 2;8(2):161–170. doi: 10.1080/19466315.2015.1135185

Table 2.

Acceptance and rejection numbers used for trial design, (r1(j),r2(j)) for the test statistics given in Equations 4 and 6.

ε1 = 0.20, ε2 = 0.20 ε1 = 0.20, ε2 = 0.20
q0 = 0.05, q1 = 0.30 q0 = 0.15, q1 = 0.30
r1(j),r2(j) r1(j),r2(j)
Patient No. for T1 for T3 for T1 for T3
1 ( - , - ) ( - , 1 ) ( - , - ) ( - , - )
2 ( - , - ) ( - , 1 ) ( - , 2 ) ( - , 2 )
3 ( - , 2 ) ( - , 2 ) ( - , 2 ) ( - , 3 )
4 ( - , 2 ) ( - , 2 ) ( - , 2 ) ( - , 3 )
5 ( - , 2 ) ( 0 , 2 ) ( - , 3 ) ( - , 3 )
6 ( - , 2 ) ( 0 , 2 ) ( 1 , 3 ) ( - , 3 )
7 ( - , 2 ) ( 0 , 2 ) ( 1 , 3 ) ( - , 4 )
8 ( 1 , 2 ) ( 0 , 2 ) ( 1 , 3 ) ( 0 , 4 )
9 ( 1 , 3 ) ( 0 , 2 ) ( 1 , 4 ) ( 0 , 4 )
10 ( 1 , 3 ) ( 0 , 3 ) ( 1 , 4 ) ( 0 , 4 )
11 ( 1 , 3 ) ( 0 , 3 ) ( 2 , 4 ) ( 0 , 4 )
12 ( 1 , 3 ) ( 1 , 3 ) ( 2 , 4 ) ( 1 , 5 )
13 ( 1 , 3 ) ( 1 , 3 ) ( 2 , 5 ) ( 1 , 5 )
14 ( 1 , 3 ) ( 1 , 3 ) ( 2 , 5 ) ( 1 , 5 )
15 ( 2 , 4 ) ( 1 , 3 ) ( 2 , 5 ) ( 1 , 5 )
16 ( 2 , 4 ) ( 1 , 3 ) ( 3 , 5 ) ( 1 , 6 )
17 ( 2 , 4 ) ( 1 , 4 ) ( 3 , 6 ) ( 2 , 6 )
18 ( 2 , 4 ) ( 1 , 4 ) ( 3 , 6 ) ( 2 , 6 )
19 ( 2 , 4 ) ( 2 , 4 ) ( 3 , 6 ) ( 2 , 6 )
20 ( 2 , 4 ) ( 2 , 4 ) ( 3 , 6 ) ( 2 , 6)